Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

HeartSciences (HSCS) Cost of Revenue (2021 - 2025)

HeartSciences filings provide 5 years of Cost of Revenue readings, the most recent being $1008.0 for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 98.96% to $1008.0 in Q4 2025 year-over-year; TTM through Jan 2026 was $3648.0, a 98.14% decrease, with the full-year FY2025 number at $1880.0, down 69.08% from a year prior.
  • Cost of Revenue hit $1008.0 in Q4 2025 for HeartSciences, up from $760.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $99091.0 in Q3 2024 to a low of $760.0 in Q1 2023.
  • Median Cost of Revenue over the past 5 years was $1700.0 (2023), compared with a mean of $18048.9.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 6286.91% in 2024 and later crashed 99.23% in 2025.
  • HeartSciences' Cost of Revenue stood at $5756.0 in 2021, then crashed by 64.63% to $2036.0 in 2022, then decreased by 25.34% to $1520.0 in 2023, then skyrocketed by 6286.91% to $97081.0 in 2024, then crashed by 98.96% to $1008.0 in 2025.
  • The last three reported values for Cost of Revenue were $1008.0 (Q4 2025), $760.0 (Q3 2025), and $1880.0 (Q2 2025) per Business Quant data.